By: Paul Arora
We are thrilled to announce a strategic partnership between Inka Health and GIPAM GmbH, marking a significant milestone in our mission to advance Health Economics and Outcomes Research (HEOR) and regulatory science. This collaboration unites two teams, poised to set new standards in the generation of real-world evidence (RWE) and the application of advanced analytics within the healthcare sector.
At Inka Health, we recognize the immense value that high-quality data brings to robust healthcare research. Partnering with GIPAM GmbH, renowned for its unparalleled access to European and US real-world data and expertise in multi-country retrospective database studies, feels like a perfect synergy. GIPAM’s advanced analytical capabilities and strategic market access support complement our specialized expertise in advanced analytics, including indirect treatment comparisons and real-world oncology evidence generation.
Reflecting on this partnership, we feel incredibly fortunate to collaborate with a team that shares our commitment to excellence and innovation. GIPAM’s proficiency in areas such as rare diseases and complex treatment scenarios provides a solid foundation for our joint efforts. Together, we are equipped to deliver comprehensive RWE solutions that empower our collaborators to navigate the complexities of the regulatory landscape with confidence and precision.
This collaboration is not just about combining strengths; it’s about creating a synergy that enhances the value we offer to our partners and clients. By merging GIPAM’s extensive data access and analytical expertise with Inka Health’s innovative approaches, we are set to influence healthcare decision-making on a global scale. Our joint efforts will ensure that the research conducted is not only scientifically robust but also strategically positioned to drive meaningful outcomes in healthcare policy and practice.
We extend our heartfelt gratitude to the teams at GIPAM GmbH for their trust and partnership. Together, we are poised to make significant advancements in HEOR and regulatory science, setting new benchmarks for excellence in healthcare research. We look forward to the impactful work ahead and the positive changes our collaboration will bring to the healthcare landscape.
Stay tuned for more updates as we embark on this exciting journey together. Thank you for your continued support and trust in Inka Health.
About Inka Health:
Inka Health is a pioneer in health economics and outcomes research, specializing in the generation of real-world evidence and advanced analytics. Based in Toronto, Canada, we are dedicated to supporting healthcare decisions and policy-making with robust, actionable evidence.
About GIPAM GmbH:
GIPAM GmbH is a Germany-based analytics services company renowned for its access to European real-world data and expertise in conducting comprehensive retrospective database studies. GIPAM is at the forefront of advancing evidence-based research across various therapeutic areas.
Comments